A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.
← catalyst calendarSponsored by Pfizer (industry) · PFE — their whole pipeline →.
Phase
Phase 1
Status
Active, not recruiting
Study type
Interventional
Design
Non randomized · None · Basic science
Enrollment
14actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-05-05 | actual | When the study began enrolling |
| Primary completion | 2026-06-26 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-07-23 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-08 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Participant
Interventions
- Drug: PF-08642534
- Drug: Itraconazole
Primary outcome
what the primary-completion date above is the date OFPF-08642534 Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast)
measured 0 to 240 hours post-dose
Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed